Divergent trends for gastric cancer incidence by anatomical subsite in US adults.
about
Gastric Cancer: How Can We Reduce the Incidence of this Disease?Height, weight, and body mass index associations with gastric cancer subsitesTreatment of early gastric cancer in the Western World.Inflammation and Gli2 suppress gastrin gene expression in a murine model of antral hyperplasiaContribution of H. pylori and smoking trends to US incidence of intestinal-type noncardia gastric adenocarcinoma: a microsimulation modelCancer stem cell hypothesis and gastric carcinogenesis: Experimental evidence and unsolved questions.The descriptive epidemiology of gastric cancer in Central America and comparison with United States Hispanic populations.Overexpression of FGFR2 contributes to inherent resistance to MET inhibitors in MET-amplified patient-derived gastric cancer xenografts.Gastric tumor development in Smad3-deficient mice initiates from forestomach/glandular transition zone along the lesser curvature.Epstein-barr virus infected gastric adenocarcinoma expresses latent and lytic viral transcripts and has a distinct human gene expression profileAge-specific effects on the prognosis after surgery for gastric cancer: A SEER population-based analysis.Multimodal treatment of esophageal cancer.Inhibition of Hedgehog signaling in the gastrointestinal tract: targeting the cancer microenvironment.Long-term Trends in Primary Sites of Gastric Adenocarcinoma in Japan and the United States.Influence of metabolic syndrome on upper gastrointestinal disease.Recapitulating Human Gastric Cancer Pathogenesis: Experimental Models of Gastric Cancer.The safety and efficacy of ramucirumab in combination with paclitaxel for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma.Gastric adenocarcinoma.Changing Trends in Stomach Cancer Throughout the World.Acid-suppressing therapies and subsite-specific risk of stomach cancer.Trends in gastric cancer incidence: a period and birth cohort analysis in a well-defined French population.General and abdominal obesity and risk of esophageal and gastric adenocarcinoma in the European Prospective Investigation into Cancer and Nutrition.Relationship between body mass index and the risk of early gastric cancer and dysplasia regardless of Helicobacter pylori infection.Gastric cancer incidence among Hispanics in California: patterns by time, nativity, and neighborhood characteristics.Registry of gastric cancer treatment evaluation (REGATE): I baseline disease characteristics.Age and sex interactions in gastric cancer incidence and mortality trends in Korea.Comprehensive assessment and meta-analysis of the association between CTNNB1 polymorphisms and cancer risk.Proportion and number of cancer cases and deaths attributable to potentially modifiable risk factors in the United States.The Changing Face of Noncardia Gastric Cancer Incidence Among US Non-Hispanic Whites.Serum pepsinogen 1 and anti-Helicobacter pylori IgG antibodies as predictors of gastric cancer risk in Finnish males.Gastric cancer: epidemiology, prevention, classification, and treatment.Acid and the basis for cellular plasticity and reprogramming in gastric repair and cancer.A New Gastric Cancer Among Us.Familial gastric cancer: guidelines for diagnosis, treatment and periodic surveillance.Effect of fluorouracil, leucovorin, and oxaliplatin with or without onartuzumab in epidermal growth factor receptor-2-negative, mesenchymal-epithelial transition-positive gastroesophageal adenocarcinoma: is it a real failure?
P2860
Q26749352-4D8F1471-0D10-4137-B265-BF0A50B460C0Q33555888-DB118CCF-6FD5-4290-875A-6ADD2224D1DEQ33626791-FEFED6BA-851C-40D5-A7D2-635B04321DB6Q34460882-3CFE28E9-9D1D-4D75-8509-769A038BBA33Q34734891-2EF88B0B-3823-48F0-93E1-A276A88CF99CQ35854500-62AD37C6-03D1-40D6-8D15-E707FF894F6EQ35854625-8B22A169-13D3-4405-9A0B-C810E7834A4AQ36085827-FADBD600-D3DB-4CF2-82F8-A1B9BB722DCCQ36644279-5F047DC1-5827-4DF2-BB98-0C02D7A954A2Q36687528-747CCFD0-6E43-4669-9F05-12E0DB91B098Q37565561-C5858B90-0B1B-4C41-AF9F-0B96631A30CDQ38042808-DB11DD0F-E74E-449A-B328-D1CEA9B2BBA7Q38134486-0E4134AA-72D0-4169-A886-6F8430ADE79DQ38619024-CB2B7E47-87F4-406F-9C50-898C2C399B16Q38884267-D7B6D1D5-C106-44B7-8C23-C435E26F7F33Q38940560-FE4DDD54-4C9E-4721-85EE-721E3F4D205AQ38942944-5A8AF3DF-1D02-49D8-9C25-169CB35310DFQ39343374-602D8D08-B396-4BC5-B315-C97B47CFFFF6Q39449701-65B43E7A-F8D4-4373-9E02-D728FB328AEEQ40270202-1218462C-6C3E-4B1F-901C-F9C2F3534C4EQ40789242-C0B3203C-0711-4934-BF1F-F556906B72BFQ41566014-A1FD468A-8CF3-4342-98CD-7EEF917C0549Q41732158-A9DB4F9D-C1F2-47A4-8C3A-ED1CC091B888Q45983842-27D34D50-EA45-4C55-AD4B-AF3267D2F690Q46321211-A0CDA95F-992B-4FE6-BBAE-9C9E94BB4B6CQ46859658-5EC0FE5E-AEAE-4FA1-ADBD-1F30F6759FECQ47134663-76D382E5-06F0-43B3-8DBB-F7849CB82DF0Q47210863-C58AE4B2-18E8-422C-A3F0-7174A31CEE41Q47716875-39250EB9-9036-4453-B6D2-DEE7D92C4A02Q48111399-1DD0FAFB-4903-4CBA-9536-98B7C2C2419CQ49702243-00E2635F-0C18-466C-8FF2-12D1C0022A44Q49788912-69F503C4-82E1-470E-B1F0-F614807A1908Q52707757-EF2DFBFE-537C-4B56-B1A9-F0E2119AAE70Q53134388-DFE516ED-C77F-4850-B3EA-2FE8BBFD1C60Q58555802-1104D084-6E28-4B6B-A192-6694CD17BF7F
P2860
Divergent trends for gastric cancer incidence by anatomical subsite in US adults.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Divergent trends for gastric cancer incidence by anatomical subsite in US adults.
@ast
Divergent trends for gastric cancer incidence by anatomical subsite in US adults.
@en
type
label
Divergent trends for gastric cancer incidence by anatomical subsite in US adults.
@ast
Divergent trends for gastric cancer incidence by anatomical subsite in US adults.
@en
prefLabel
Divergent trends for gastric cancer incidence by anatomical subsite in US adults.
@ast
Divergent trends for gastric cancer incidence by anatomical subsite in US adults.
@en
P2093
P2860
P356
P1433
P1476
Divergent trends for gastric cancer incidence by anatomical subsite in US adults.
@en
P2093
Charles S Rabkin
Cheryll C Thomas
Christie R Eheman
Jessica B King
M Constanza Camargo
Pelayo Correa
Philip S Rosenberg
William F Anderson
P2860
P304
P356
10.1136/GUT.2010.236737
P407
P577
2011-05-25T00:00:00Z